
Dolby Laboratories (DLB) Stock Forecast & Price Target
Dolby Laboratories (DLB) Analyst Ratings
Bulls say
Dolby Laboratories Inc. recorded a 1.6% year-over-year increase in product and service revenue, driven by stronger-than-expected growth fueled by the timing of deal closures. The company's strategic focus on expanding its Premium Large Format (PLF) cinema concept and the growing adoption of technologies such as Atmos and Vision has positioned it for significant revenue increases, particularly in licensing, which constitutes nearly half of the total revenues. Additionally, Dolby Laboratories aims to enhance future growth through innovative SaaS-like models related to patent licensing and its OptiView solution, setting a strong foundation for sustained financial performance.
Bears say
Dolby Laboratories Inc. is facing a negative outlook due to expected declines in key revenue categories, with a projected 7.5% year-over-year decrease in licensing revenue and a 5.7% drop in products and services for the December quarter. Additionally, operating expenses are anticipated to increase by 5.5% year-over-year, exacerbating the company's profitability challenges as gross margins decreased from 90.8% to 89.8%. Further complicating the financial landscape, the company is anticipating a similar high-single-digit revenue decline for fiscal 2026, mirroring the downturn experienced in fiscal 2025, as overall expectations in the PC and consumer electronics markets remain weak.
This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.
Dolby Laboratories (DLB) Analyst Forecast & Price Prediction
Start investing in Dolby Laboratories (DLB)
Order type
Buy in
Order amount
Est. shares
0 shares